Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS, especially those overweight, have higher levels of IL-18 in their endometrium, which may affect fertility.

Platelet-rich plasma may improve embryo genetics in IVF.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

The combined therapy improved symptoms in PCOS patients.

Melatonin may help treat PCOS symptoms in rats.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Stem cells are crucial for tissue growth, cancer treatment, and disease modeling, but challenges remain in clinical use.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Minoxidil boosts hair growth by triggering growth factor release from specific stem cells.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

The microenvironment controls adult stem cells' behavior and fate.

NBCCS and BFHS might be the same syndrome, helping better identify and manage cases.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Stem cells compete for space using cell adhesion, and mutations can affect their competitive success, with implications for tissue health and disease.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Low intensity ultrasound may reduce side effects of chemotherapy drugs like paclitaxel.

Statins may be linked to reproductive organ conditions, and their risks should be monitored.

Finasteride reduces testosterone conversion, progesterone lessens this, and levamisole enhances finasteride's effect.